MEF2C and acute lymphoblastic leukemia: Studies have shown that MEF2C acts as a transcriptional regulator for genes that are expressed in the immature subgroup of T-ALL, including lymphoblastic leukemia-derived sequence 1 (Lyl1 ) and LIM Domain Only 2 (LMO2) [10].